Meanwhile, miR-146a inhibition increased p-AKT protein expression, and it did not change AKT protein expression in either cellular AD model, which supported our hypothetical explanation that miR-146a inhibition might induce the activation of AKT in cellular AD models. The gene discussed is AKT1; the disease is Alzheimer disease.